Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board
Incannex Healthcare (NASDAQ:IXHL) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program
Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards
Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026 [Yahoo! Finance]